Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA.
Ye LF, Huang ZY, Chen XX, Chen ZG, Wu SX, Ren C, Hu MT, Bao H, Jin Y, Wang F, Wang FH, Du ZM, Wu X, Ju HQ, Shao Y, Li YH, Xu RH, Wang DS.
Ye LF, et al. Among authors: wang f, wang ds, wang fh.
Drug Resist Updat. 2022 Dec;65:100883. doi: 10.1016/j.drup.2022.100883. Epub 2022 Sep 29.
Drug Resist Updat. 2022.
PMID: 36202008
Free article.